.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
US Department of Justice
Federal Trade Commission
Express Scripts
Johnson and Johnson
AstraZeneca
McKinsey
Queensland Health
UBS
Teva

Generated: July 23, 2017

DrugPatentWatch Database Preview

Clorazepate dipotassium - Generic Drug Details

« Back to Dashboard

What are the generic sources for clorazepate dipotassium and what is the scope of clorazepate dipotassium freedom to operate?

Clorazepate dipotassium
is the generic ingredient in four branded drugs marketed by Quantum Pharmics, Recordati Rare, Mylan, Sun Pharm Inds Ltd, Aurolife Pharma Llc, Lederle, Purepac Pharm, Gd Searle Llc, Warner Chilcott, Am Therap, Taro Pharm, Dava Pharms Inc, Usl Pharma, Watson Labs, Able, and Alra, and is included in sixty-four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for clorazepate dipotassium. Nine suppliers are listed for this compound.

Summary for Generic Name: clorazepate dipotassium

Tradenames:4
Patents:1
Applicants:16
NDAs:64
Drug Master File Entries: see list8
Suppliers / Packagers: see list9
Bulk Api Vendors: see list24
Clinical Trials: see list3
Patent Applications: see list670
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:clorazepate dipotassium at DailyMed

Pharmacology for Ingredient: clorazepate dipotassium

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Warner Chilcott
CLORAZEPATE DIPOTASSIUM
clorazepate dipotassium
TABLET;ORAL071829-001Mar 3, 1988DISCNNoNo► Subscribe► Subscribe
Sun Pharm Inds Ltd
CLORAZEPATE DIPOTASSIUM
clorazepate dipotassium
TABLET;ORAL076911-001Sep 29, 2004ABRXNoNo► Subscribe► Subscribe
Taro Pharm
CLORAZEPATE DIPOTASSIUM
clorazepate dipotassium
TABLET;ORAL075731-003Apr 27, 2000ABRXNoNo► Subscribe► Subscribe
Gd Searle Llc
CLORAZEPATE DIPOTASSIUM
clorazepate dipotassium
CAPSULE;ORAL071727-001Dec 18, 1987DISCNNoNo► Subscribe► Subscribe
Alra
GEN-XENE
clorazepate dipotassium
TABLET;ORAL071789-001Apr 26, 1988ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: clorazepate dipotassium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Recordati Rare
TRANXENE
clorazepate dipotassium
TABLET;ORAL017105-007Approved Prior to Jan 1, 1982RE28315► Subscribe
Recordati Rare
TRANXENE
clorazepate dipotassium
TABLET;ORAL017105-008Approved Prior to Jan 1, 1982RE28315► Subscribe
Recordati Rare
TRANXENE
clorazepate dipotassium
CAPSULE;ORAL017105-001Approved Prior to Jan 1, 1982RE28315► Subscribe
Recordati Rare
TRANXENE SD
clorazepate dipotassium
TABLET;ORAL017105-005Approved Prior to Jan 1, 1982RE28315► Subscribe
Recordati Rare
TRANXENE
clorazepate dipotassium
CAPSULE;ORAL017105-003Approved Prior to Jan 1, 1982RE28315► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Daiichi Sankyo
McKinsey
Farmers Insurance
Deloitte
Harvard Business School
Medtronic
Fuji
Accenture
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot